Literature DB >> 6811269

Procollagen N-proteinase. Properties of the enzyme purified from chick embryo tendons.

L Tuderman, D J Prockop.   

Abstract

Procollagen N-proteinase was purified about 3700-fold from chick embryo tendons. Electrophoresis of the protein after iodination and denaturation suggested it was homogeneous. However, the native enzyme could not be examined by gel electrophoresis, and therefore homogeneity of the preparation was not conclusively established. Antibodies to the enzyme completely inhibited activity and gave a single precipitant line by double immuno-diffusion. The Km for a native procollagen substrate was 0.3-0.5 microM. The same protein after denaturation inhibited activity. The enzyme did not cleave type III procollagen from human fibroblasts or a type IV procollagen from a mouse sarcoma. Ca2+ was required for maximal enzymic activity. The data suggested a second metal requirement, but this was not identified. Reducing agents and metal chelators inhibited activity, but there was little if any inhibition from several inhibitors of other neutral metalloproteinases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6811269     DOI: 10.1111/j.1432-1033.1982.tb06716.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Doxorubicin-induced inhibition of prolyl hydroxylation during collagen biosynthesis in human skin fibroblast cultures. Relevance to imparied wound healing.

Authors:  T Sasaki; K C Holeyfield; J Uitto
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

2.  Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen.

Authors:  L T Smith; W Wertelecki; L M Milstone; E M Petty; M R Seashore; I M Braverman; T G Jenkins; P H Byers
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

Review 3.  Prolyl 4-hydroxylase activity-responsive transcription factors: from hydroxylation to gene expression and neuroprotection.

Authors:  Ambreena Siddiq; Leila R Aminova; Rajiv R Ratan
Journal:  Front Biosci       Date:  2008-01-01

4.  Purification of human procollagen type III N-proteinase from placenta and preparation of antiserum.

Authors:  R Halila; L Peltonen
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

Review 5.  Fell Muir Lecture: Collagen fibril formation in vitro and in vivo.

Authors:  Karl E Kadler
Journal:  Int J Exp Pathol       Date:  2017-05-16       Impact factor: 1.925

6.  Effect of fibrostatin C, an inhibitor of prolyl 4-hydroxylase, on collagen secretion by human Tenon's capsule fibroblasts in vitro.

Authors:  S Saika; A Ooshima; O Yamanaka; Y Okada; S Tanaka; Y Ohnishi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

Review 7.  The "other" 15-40%: The Role of Non-Collagenous Extracellular Matrix Proteins and Minor Collagens in Tendon.

Authors:  Nandaraj Taye; Stylianos Z Karoulias; Dirk Hubmacher
Journal:  J Orthop Res       Date:  2019-08-26       Impact factor: 3.494

8.  Inhibition of prolyl hydroxylation and procollagen processing in chick-embryo calvaria by a derivative of pyridine-2,4-dicarboxylate. Characterization of the diethyl ester as a proinhibitor.

Authors:  G Tschank; D G Brocks; K Engelbart; J Mohr; E Baader; V Günzler; H M Hanauske-Abel
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

9.  Type I collagen in Hsp47-null cells is aggregated in endoplasmic reticulum and deficient in N-propeptide processing and fibrillogenesis.

Authors:  Yoshihito Ishida; Hiroshi Kubota; Akitsugu Yamamoto; Akira Kitamura; Hans Peter Bächinger; Kazuhiro Nagata
Journal:  Mol Biol Cell       Date:  2006-03-08       Impact factor: 4.138

10.  Recovery of extracellular matrix components by enalapril maleate during the repair process of ultraviolet B-induced wrinkles in mouse skin.

Authors:  Yuko Matsuura-Hachiya; Yuji Nakai; Keiko Abe; Toshio Nishiyama; Koji Y Arai
Journal:  Biochem Biophys Rep       Date:  2015-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.